← All sarcoma trials
Recruiting nowN/AAges 18 Years and up

Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatment.

Sponsor: Centre Oscar Lambret · NCT06211257 on ClinicalTrials.gov ↗

Conditions studied

Sarcoma MetastaticLocally Advanced Soft Tissue Sarcoma

What it tests

  • Dematerialized Personalized Care Plan (ePCP)other

Where it's running11 sites

11 international sites
  • Centre Léon Bérard

    Lyon, Auvergne-Rhône-Alpes, France 69373

    Recruiting now
  • CHU Jean Minjoz

    Besançon, Bourgogne-Franche-Comté, France 25000

    Recruiting now
  • Centre Eugène Marquis

    Rennes, Brittany Region, France 35042

    Opening soon
  • Centre Paul Strauss

    Strasbourg, Grand Est, France 67033

    Recruiting now
  • Centre Oscar Lambret

    Lille, Hauts-de-France, France 59020

    Recruiting now
  • CHU de Poitiers

    Poitiers, New Aquitaine, France 86021

    Recruiting now
  • Institut Claudius Regaud

    Toulouse, Occitanie, France 31059

    Withdrawn
  • Institut de Cancérologie de l'Ouest

    Saint-Herblain, Pays de la Loire Region, France 44805

    Recruiting now
  • Institut de Cancérologie de Lorraine

    Vandœuvre-lès-Nancy, France 54519

    Opening soon
  • Hôpital Pitié-Salpêtrière AP-HP

    Paris, Île-de-France Region, France 75013

    Opening soon
  • Gustave Roussy

    Villejuif, Île-de-France Region, France 94800

    Recruiting now
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Sarcomas of soft tissues or viscera ;
* Inoperable metastatic or locally advanced disease ;
* Indication for systemic treatment with pazopanib, trabectedine, eribulin, ifosfamide or dacarbazine monotherapy ;
* Patient covered by French social security ;
* Written, signed, informed consent ;

Exclusion Criteria:

* Prior inclusion in ePPS trial for a prior systemic treatment ;
* Poor understanding of French ;
* Difficulty accessing a computer ;
* Pregnant or nursing woman ;
* Person deprived of liberty or under guardianship ;
* Impossibility of undergoing medical follow-up for geographical, social or psychological reasons.

Updated 2026-03-18 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.